We are live on ! Find out more
NRD

Nebula Research & Development Portfolio holdings

AUM $1.17B
1-Year Est. Return 15.19%
This Fund
S&P 500
This Quarter Est. Return
+7.19%
1 Year Est. Return
+15.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$836M
AUM Growth
+$219M
Cap. Flow
+$188M
Cap. Flow %
22.5%
Top 10 Hldgs %
4.49%
Holding
1,220
New
441
Increased
247
Reduced
213
Closed
319

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$4.41M
2
AAP icon
Advance Auto Parts
AAP
+$4.15M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.96M
4
DLTR icon
Dollar Tree
DLTR
+$3.82M
5
MSFT icon
Microsoft
MSFT
+$3.74M

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$2.82M
2
KO icon
Coca-Cola
KO
+$2.82M
3
GD icon
General Dynamics
GD
+$2.82M
4
ORCL icon
Oracle
ORCL
+$2.81M
5
HLNE icon
Hamilton Lane
HLNE
+$2.8M

Sector Composition

Rank Sector Weight
1 Technology 16.51%
2 Industrials 15.72%
3 Consumer Discretionary 15.68%
4 Healthcare 13.43%
5 Financials 10.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NBR icon
801
Nabors Industries
NBR
$1.12B
$220K 0.03%
3,413
-1,458
-30% -$112K
SLNO
802
DELISTED
Soleno Therapeutics
SLNO
$220K 0.03%
+4,358
New +$209K
PRA
803
DELISTED
ProAssurance
PRA
$218K 0.03%
14,481
-10,781
-43% -$138K
GBDC icon
804
Golub Capital BDC
GBDC
$3.38B
$216K 0.03%
14,264
-90,980
-86% -$1.37M
NWSA icon
805
News Corp Class A
NWSA
$15.3B
$215K 0.03%
+8,080
New +$220K
SA
806
Seabridge Gold
SA
$2.69B
$215K 0.03%
+12,800
New +$208K
GWRE icon
807
Guidewire Software
GWRE
$13.3B
$215K 0.03%
+1,174
New +$178K
AGL icon
808
Agilon Health
AGL
$1.65B
$215K 0.03%
+2,184
New +$282K
OS
809
DELISTED
OneStream Inc
OS
$215K 0.03%
+6,329
New +$187K
HZO icon
810
MarineMax
HZO
$782M
$214K 0.03%
+6,072
New +$198K
LIF
811
Life360
LIF
$4.59B
$213K 0.03%
+5,416
New +$190K
FLNC icon
812
Fluence Energy
FLNC
$1.68B
$211K 0.03%
+9,276
New +$168K
SKT icon
813
Tanger
SKT
$4.84B
$210K 0.03%
6,325
-78,582
-93% -$2.29M
REG icon
814
Regency Centers
REG
$14.8B
$209K 0.03%
+2,894
New +$200K
TROX icon
815
Tronox
TROX
$981M
$208K 0.02%
14,241
+3,065
+27% +$43.7K
HAYW icon
816
Hayward Holdings
HAYW
$3.28B
$207K 0.02%
+13,485
New +$187K
PLMR icon
817
Palomar
PLMR
$3.79B
$207K 0.02%
+2,183
New +$201K
DHI icon
818
D.R. Horton
DHI
$42.3B
$206K 0.02%
1,079
-706
-40% -$124K
KHC icon
819
Kraft Heinz
KHC
$32.4B
$205K 0.02%
+5,846
New +$201K
FND icon
820
Floor & Decor
FND
$6.14B
$205K 0.02%
+1,649
New +$171K
PCRX icon
821
Pacira BioSciences
PCRX
$1.05B
$204K 0.02%
+13,561
New +$232K
RCL icon
822
Royal Caribbean
RCL
$86.5B
$203K 0.02%
+1,147
New +$186K
CENTA icon
823
Central Garden & Pet Co Class A
CENTA
$2.44B
$203K 0.02%
+6,473
New +$215K
EFX icon
824
Equifax
EFX
$22B
$203K 0.02%
+691
New +$195K
FCN icon
825
FTI Consulting
FCN
$5.04B
$203K 0.02%
892
-2,676
-75% -$595K
31 32
33
34 35

Similar funds

SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return

Nebula Research & Development's Q3 2024 Portfolio in Review

As of Q3 2024, Nebula Research & Development held 1,220 positions worth $836M, up 35% from $618M the previous quarter. Its ten largest holdings account for 4.5% of the portfolio.

Nebula Research & Development deployed $188M of net new capital in Q3 2024, opening 441 new positions and adding to 247 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Travelers Companies, an estimated $2.39M trimmed.

  • Nebula Research & Development's largest Q3 2024 buy was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.
  • Nebula Research & Development added most to Dollar Tree in Q3 2024, an estimated $3.82M increase.
  • Nebula Research & Development's biggest Q3 2024 reduction was Travelers Companies, cutting an estimated $2.39M.
  • Nebula Research & Development fully exited Bank of America in Q3 2024, selling an estimated $2.82M.
  • Nebula Research & Development's ten largest holdings make up 4.5% of its $836M portfolio in Q3 2024.
  • Nebula Research & Development opened 441 new positions and closed 319 in Q3 2024.
  • Nebula Research & Development's portfolio value rose 35% quarter-over-quarter to $836M.

Based on Nebula Research & Development's 13F filing for Q3 2024, filed 14 Nov 2024.